PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0

[Farooqji]

clinicaltrials.gov/ct2/show...

[MBAnderson]

Here is another study currently being run with KO 706,

clinicaltrials.gov/ct2/show...

Nilotinib is a tyrosine kinase inhibitor, so I suspect it's another cancer drug? Do you know what it is?

[Farooqji in reply to MBAnderson]

You are right

cancer.gov/publications/dic...